In vivo biological standardization of Olea europaea allergen extracts.

Condition studied

Allergies

Investigational medicinal product(s)

Eligibility

Primary endpoint

The area of the wheal (mm2) that occurs at the cutaneous level after the administration of the extracts in the prick test for the calculation of the primary endpoint., Estimation of the dose/response relationship in each patient; regression analysis of area values versus concentration in PNU/ml., Determination of the theoretical concentration of extract that produces a papule equivalent to that produced by a solution of histamine at 10 mg/ml

Endpoint detail

Safety assessment through descriptive analysis of adverse reactions that could occur during the course of the study